Relation among p130Cas, E-cadherin and β-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 5, 2008, Pages 490-496

  Guo, Cheng ^a   Liu, Qing Guang ^a   Yang, Wei ^a   Zhang, Zheng Liang ^a   Yao, Ying Min ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

catenin; E cadherin; Hepatocellular carcinoma; Metastasis; P130Cas

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; CRK ASSOCIATED SUBSTRATE PROTEIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TUMOR VOLUME;

ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CRK-ASSOCIATED SUBSTRATE PROTEIN; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 55049125543     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bouton AH, Riggins RB, Bruce-Staskal PJ. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 2001;20: 6448-6458.
2. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002;4:E83-90.
3. Brábek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, Hanks SK. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res 2005; 3:307-315.
4. Li YJ, Meng YX, Ji XR. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer. Hepatobiliary Pancreat Dis Int 2003;2:471-477.
5. Pan SL, Chen XP, Zhang WG, Li GP. Significance and expression of p130Cas and Paxillin in humen hepatocellular carcinomas. Zhonghua Wai Ke Za Zhi 2006;44:1648-1649.
6. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75: 734-738.
7. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-359.
8. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000;59:302-309.
9. Matsuda M, Mayer BJ, Fukui Y, Hanafusa H. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 1990;248: 1537-1539.
10. Reynolds AB, Kanner SB, Wang BC, Parsons JT. Stable association of activated pp60src with two tyrosinep-hosphorylated cellular proteins. Mol Cell Biol 1989;9: 3951-3958.
11. Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T, et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998;19:361-365.
12. Panetti TS. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci 2002;7:d143-150.
13. Schrecengost RS, Riggins RB, Thomas KS, Guerrero MS, Bouton AH. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res 2007;67:6174-6182.
14. Scibelli A, d'Angelo D, Pelagalli A, Tafuri S, Avallone L, Della Morte R, et al. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors. Vet Res 2003;34:193-202.
15. Zhang XA, He B, Zhou B, Liu L. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. J Biol Chem 2003;278:27319-27328.
16. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113:173-185.
17. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-193.
18. Wang QM, Yang KM, Zhou HY, Yu ZH, Li X, Yang HJ. Role of beta-catenin in hepatocarcinogenesis of rats. Hepatobiliary Pancreat Dis Int 2006;5:85-89.
19. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119.
20. Cui J, Zhou X, Liu Y, Tang Z. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people. J Cancer Res Clin Oncol 2001;127:577-581.
21. Di Florio A, Capurso G, Milione M, Panzuto F, Geremia R, Delle Fave G, et al. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer 2007;14:111-124.
22. Heasman J, Crawford A, Goldstone K, Garner-Hamrick P, Gumbiner B, McCrea P, et al. Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 1994; 79:791-803.